Bridle, KR, Frazer, DM, Wilkins, SJ, et al. (2003) Disrupted hepcidin regulation in HFE-associated haemochromatosis and the liver as a regulator of body iron homoeostasis. Lancet 361, 669–673.
Brookes, MJ, Sharma, NK, Tselepis, C & Iqbal, TH (2005) Serum pro-hepcidin: measuring active hepcidin or a non-functional precursor? Gut 54, 169–170.
Carter, P (1971) Spectrophotometric determination of serum iron at the submicrogram level with a new reagent (ferrozine). Anal Biochem 40, 450–458.
Dallalio, G, Fleury, T & Means, RT (2003) Serum hepcidin in clinical specimens. Br J Haematol 122, 996–1000.
Ezeh, C, Ugochukwu, CC, Weinstein, J & Okpala, I (2005) Hepcidin, haemoglobin and ferritin levels in sickle cell anaemia. Eur J Haematol 74, 86–88.
Flowers, CA, Kuizon, M, Beard, JL, Skikne, BS, Covell, AM & Cook, JD (1986) A serum ferritin assay for prevalence studies of iron deficiency. Am J Hematol 23, 141–151.
Gehrke, SG, Kulaksiz, H, Herrmann, T, Riedel, HD, Bents, K, Veltkamp, C & Stremmel, W (2003) Expression of hepcidin in hereditary hemochromatosis: evidence for a regulation in response to the serum transferrin saturation and to non-transferrin-bound iron. Blood 102, 371–376.
Heath, A-L & Fairweather-Tait, S (2003) Health implications of iron overload: the role of diet and genotype. Nutr Rev 61, 45–62.
Hsu, SP, Chiang, CK, Chien, CT & Hung, KY (2006) Plasma prohepcidin positively correlates with hematocrit in chronic hemodialysis patients. Blood Purif 24, 311–316.
Hunter, HN, Fulton, DB, Ganz, T & Vogel, HJ (2002) The solution structure of human hepcidin, a peptide hormone with antimicrobial activity that is involved in iron uptake and hereditary hemochromatosis. J Biol Chem 277, 37597–37603.
Kemna, E, Tjalsma, H, Laarakkers, C, Nemeth, E, Willems, H & Swinkels, D (2005) Novel urine hepcidin assay by mass spectrometry. Blood 106, 3268–3270.
Krause, A, Neitz, S, Mägert, H-J, Schulz, A, Forssmann, WG, Schulz-Knappe, P & Adermann, K (2000) LEAP-1, a novel highly disulfide-bonded human peptide, exhibits antimicrobial activity. FEBS Lett 480, 147–150.
Kulaksiz, H, Gehrke, SG, Janetzko, A, Rost, D, Bruckner, T, Kallinowski, B & Stremmel, W (2004) Pro-hepcidin: expression and cell specific localisation in the liver and its regulation in hereditary haemochromatosis, chronic renal insufficiency, and renal anaemia. Gut 53, 735–743.
Kulaksiz, H, Theilig, F, Bachmann, S, Gehrke, SG, Rost, D, Janetzko, A, Cetin, Y & Stremmel, W (2005) The iron-regulatory peptide hormone hepcidin: expression and cellular localization in the mammalian kidney. J Endocrinol 184, 361–370.
Laftah, AH, Ramesh, B, Simpson, RJ, Solanky, N, Bahram, S, Schumann, K, Debnam, ES & Srai, SKS (2004) Effect of hepcidin on intestinal iron absorption in mice. Blood 102, 3940–3944.
Liang, S, Clarke, W, Chan, D & Zhang, Z (2006) Novel assay for hepcidin by surface- enhanced laser desorption/ionization mass spectrometry. Clin Chem 52, .
Nemeth, E, Valore, EV, Territo, M, Schiller, G, Lichtenstein, A & Ganz, T (2003) Hepcidin, a putative mediator of anemia of inflammation, is a type II acute-phase protein. Blood 101, 2461–2463.
Nemeth, E, Tuttle, MS, Powelson, J, Vaughan, MB, Donovan, A, Ward, DM, Ganz, T & Kaplan, J (2004 a) Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science 306, 2090–2093.
Nemeth, E, Rivera, S, Gabayan, V, Keller, C, Taudorf, S, Pedersen, BK & Ganz, T (2004 b) IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin. J Clin Invest 113, 1271–1276.
Nicolas, G, Bennoun, M, Devaux, I, Beaumont, C, Grandchamp, B, Kahn, A & Vaulont, S (2001) Lack of hepcidin gene expression and severe tissue iron overload in upstream stimulatory factor 2 (USF2) knockout mice. Proc Natl Acad Sci USA 98, 8780–8785.
Nicolas, G, Bennoun, M, Porteu, A, et al. (2002) Severe iron deficiency anemia in transgenic mice expressing liver hepcidin. Proc Natl Acad Sci U S A 99, 4596–4601.
Park, CH, Valore, EV, Waring, AJ & Ganz, T (2001) Hepcidin, a urinary antimicrobial peptide synthesized in the liver. J Biol Chem 276, 7806–7810.
Pigeon, C, Ilyin, G, Courselaud, B, Leroyer, P, Turlin, B, Brissot, P & Loreal, O (2001) A new mouse liver-specific gene, encoding a protein homologous to human antimicrobial peptide hepcidin, is overexpressed during iron overload. J Biol Chem 276, 7811–7819.
Roe, MA, Heath, A-LM, Oyston, SL, et al. (2005) Iron absorption in C282Y heterozygotes. Am J Clin Nutr 81, 814–821.
Schümann, K, Kroll, S, Weiss, G, Frank, J, Biesalski, HK, Daniel, H, Friel, J & Solomons, NW (2005) Monitoring of hematological, inflammatory and oxidative reactions to acute oral iron exposure in human volunteers: preliminary screening for selection of potentially-responsive biomarkers. Toxicology 212, 10–23.
Taes, YE, Wuyts, B, Boelaert, JR, De Vriese, AS & Delanghe, JR (2004) Prohepcidin accumulates in renal insufficiency. Clin Chem Lab Med 24, 387–389.
Tomosugi, N, Kawabata, H, Wakatabe, R, Higuchi, M, Yamaya, H, Umehara, H & Ishikawa, I (2006) Detection of serum hepcidin in renal failure and inflammation by using ProteinChip System. Blood 108, 1381–1387.
Walker, AP, Partridge, J, Srai, SK & Dooley, JS (2004) Hepcidin: what every gastroenterologist should know. Gut 53, 624–627.
Willis, G, Scott, DG, Jennings, BA, Smith, K, Bukhari, M & Wimperis, JZ (2002) HFE mutations in an inflammatory arthritis population. Rheumatology 41, 176–179.
Yamaji, S, Sharp, P, Ramesh, B & Srai, SK (2004) Inhibition of iron transport across human intestinal epithelial cells by hepcidin. Blood 104, 2178–2180.